West Pharmaceutical Services (WST) EBT Margin (2009 - 2026)

West Pharmaceutical Services has disclosed EBT Margin across 18 years of filings, most recently posting 21.32% for Q1 2026.

• EBT Margin for Q1 2026 came in at 21.32%, up 549.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 20.82% (up 118.0% YoY), and the FY2025 annual result was 19.55%, down 69.0% from the prior year.
• EBT Margin came in at 21.32% for Q1 2026 at West Pharmaceutical Services, up from 20.06% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 29.46% in Q2 2022 to a low of 15.83% in Q1 2025.
• The 5-year median for EBT Margin is 21.36% (2025), against an average of 21.64%.
• Across the five-year window, EBT Margin slumped 673 bps in 2022 and jumped 549 bps in 2026, its largest moves.
• West Pharmaceutical Services' EBT Margin stood at 18.16% in 2022, then grew by 27 bps to 22.98% in 2023, then declined by 4 bps to 22.02% in 2024, then declined by 9 bps to 20.06% in 2025, then increased by 6 bps to 21.32% in 2026.
• The last three EBT Margin figures came in at 21.32% (Q1 2026), 20.06% (Q4 2025), and 21.36% (Q3 2025), per Business Quant data.